News

Editor's Pick

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed
News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

By Todd Neale
New Microbleeds Not Uncommon Post-TAVI
News Daily News

New Microbleeds Not Uncommon Post-TAVI

By Caitlin E. Cox
Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution
News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

By Michael O'Riordan

Recent News

See all

Conference Coverage

See all
Sign Up for Our Newsletter

Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD.

Search All News

Filter by

Around the Web
See all
Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy
Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients
REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy.
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly